Bortezomib Krka 1 mg powder for solution for injection 爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

bortezomib krka 1 mg powder for solution for injection

krka, d.d., novo mesto - bortezomib - powder for solution for injection - 1 milligram(s) - bortezomib

Bortezomib Krka 3.5 mg powder for solution for injection 爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

bortezomib krka 3.5 mg powder for solution for injection

krka, d.d., novo mesto - bortezomib - powder for solution for injection - 3.5 milligram(s) - bortezomib

Olmesartan/Hydrochlorothiazide Krka 40 mg/25 mg film-coated tablets 爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

olmesartan/hydrochlorothiazide krka 40 mg/25 mg film-coated tablets

krka, d.d., novo mesto - olmesartan medoxomil; hydrochlorothiazide - film-coated tablet - 40 mg/25 milligram(s) - angiotensin ii antagonists and diuretics; olmesartan medoxomil and diuretics

Olmesartan/Hydrochlorothiazide Krka 40 mg/12.5 mg film-coated tablets 爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

olmesartan/hydrochlorothiazide krka 40 mg/12.5 mg film-coated tablets

krka, d.d., novo mesto - olmesartan medoxomil; hydrochlorothiazide - film-coated tablet - 40 mg/12.5 milligram(s) - angiotensin ii antagonists and diuretics; olmesartan medoxomil and diuretics

Ezetimibe Krka 10 mg tablets 爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

ezetimibe krka 10 mg tablets

krka, d.d., novo mesto - ezetimibe - tablet - 10 milligram(s) - other lipid modifying agents; ezetimibe

Clopidogrel Krka d.d. (previously Zopya) 欧盟 - 英文 - EMA (European Medicines Agency)

clopidogrel krka d.d. (previously zopya)

krka, d.d., novo mesto - clopidogrel (as hydrochloride) - peripheral vascular diseases; stroke; myocardial infarction - antithrombotic agents - secondary prevention of atherothrombotic eventsclopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35days), ischaemic stroke (from 7days until less than 6months) or established peripheral arterial disease.adult patients suffering from acute coronary syndrome:non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa).st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy.prevention of atherothrombotic and thromboembolic events in atrial fibrillationin adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke.

Rivaroxaban Krka 10 mg film-coated tablets 爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

rivaroxaban krka 10 mg film-coated tablets

krka, d.d., novo mesto - rivaroxaban - film-coated tablet - 10 milligram(s) - rivaroxaban

DONEPEZIL KRKA 10 Milligram Orodispersible Tablet 爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

donepezil krka 10 milligram orodispersible tablet

krka d.d., novo mesto - donepezil hydrochloride - orodispersible tablet - 10 milligram

DONEPEZIL KRKA 5 Milligram Orodispersible Tablet 爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

donepezil krka 5 milligram orodispersible tablet

krka d.d., novo mesto - donepezil hydrochloride - orodispersible tablet - 5 milligram

Valsartan Krka 40mg film-coated Tablets 马耳他 - 英文 - Malta Medicines Authority

valsartan krka 40mg film-coated tablets

krka dd novo mesto Šmarješka cesta 6, 8501 novo mesto, slovenia - valsartan - film-coated tablet - valsartan 40 mg - agents acting on the renin-angiotensin system